HilleVax, Inc. financial data

Symbol
HLVX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
321 Harrison Ave, Suite 500, Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 923 % -27.7%
Debt-to-equity 25.1 % -11.6%
Return On Equity -61.3 % -9.17%
Return On Assets -49 % -12%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50.1M shares +0.89%
Common Stock, Shares, Outstanding 50.1M shares +2.13%
Entity Public Float 345M USD +33.6%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 50M shares +3.14%
Weighted Average Number of Shares Outstanding, Diluted 50M shares +3.14%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 25.9M USD -11.7%
Operating Income (Loss) -113M USD +26.6%
Nonoperating Income (Expense) 6.6M USD -38.2%
Net Income (Loss) Attributable to Parent -106M USD +25.8%
Earnings Per Share, Basic -2.15 USD/shares +34.8%
Earnings Per Share, Diluted -2.15 USD/shares +34.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 47.5M USD -66.3%
Marketable Securities, Current 112M USD -14.9%
Assets, Current 166M USD -41%
Property, Plant and Equipment, Net 4.23M USD -68.9%
Operating Lease, Right-of-Use Asset 7.23M USD -59.5%
Other Assets, Noncurrent 23K USD 0%
Assets 179M USD -43.1%
Accounts Payable, Current 72K USD -97.6%
Employee-related Liabilities, Current 283K USD -86.2%
Accrued Liabilities, Current 2.87M USD -85%
Liabilities, Current 6.55M USD -74.6%
Operating Lease, Liability, Noncurrent 20.4M USD -8.6%
Other Liabilities, Noncurrent 923K USD -45.7%
Liabilities 27.9M USD -62.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.08M USD -13.8%
Retained Earnings (Accumulated Deficit) -542M USD -24.5%
Stockholders' Equity Attributable to Parent 151M USD -36.8%
Liabilities and Equity 179M USD -43.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.7M USD +61.5%
Net Cash Provided by (Used in) Financing Activities 15.1M USD +18728%
Net Cash Provided by (Used in) Investing Activities -94.3M USD -63.5%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 50.1M shares +0.85%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -107M USD -41.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 382K USD +99%
Deferred Tax Assets, Valuation Allowance 81.3M USD +49.3%
Deferred Tax Assets, Gross 82.9M USD +41.9%
Operating Lease, Liability 24M USD -7.02%
Depreciation 1.67M USD +25.2%
Payments to Acquire Property, Plant, and Equipment 153K USD -94.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -107M USD +26%
Lessee, Operating Lease, Liability, to be Paid 31.5M USD -10.2%
Property, Plant and Equipment, Gross 6.59M USD -55.9%
Operating Lease, Liability, Current 3.6M USD +3.09%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.79M USD +2.74%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.77M USD +3.05%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.48M USD -19.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.86M USD +2.11%
Deferred Tax Assets, Operating Loss Carryforwards 24.7M USD +139%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 976K USD +1.77%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.98M USD +3.06%
Operating Lease, Payments 923K USD +3.01%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.57M USD -60.2%
Share-based Payment Arrangement, Expense 18M USD +11.6%
Interest Expense 2.91M USD +106%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%